USA flag logo/image

An Official Website of the United States Government

SBIR Phase I: Biocompatible Magnetic Drug Delivery Systems that Allow for…

Award Information

Agency:
National Science Foundation
Branch:
N/A
Award ID:
63377
Program Year/Program:
2003 / SBIR
Agency Tracking Number:
0319444
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
NANOSONIC INC.
158 WHEATLAND DR Pembroke, VA 24136-0000
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2003
Title: SBIR Phase I: Biocompatible Magnetic Drug Delivery Systems that Allow for Greatly Diminished Doses
Agency: NSF
Contract: 0319444
Award Amount: $99,999.00
 

Abstract:

This Small Business Innovation Research (SBIR) Phase I project is to develop noble metal and polymer stabilized magnetic nanoparticles and biodegradable microspheres as nanovehicles for use in magnetically guided drug delivery. Site-specific release of therapeutic agents results in greatly reduced whole body dosages to minimize toxicity. Controlled, ultra thin coatings for magnetic nanoparticles would yield biocompatible systems with significantly improved magnetic susceptibility required for effective magnetic guidance through the arterial system. Analgesics and stable magnetic nanoparticles would be contained in and subsequently released from biodegradable polymeric microspheres. The commercial applications of these highly magnetic nano-vehicles would be as Nuclear Magnetic Resonance (NMR) imaging contrast agents, magnetically guided drug delivery systems, and for cell separation techniques.

Principal Investigator:

Dr. Jennifer Lalli

Business Contact:

Small Business Information at Submission:

Nanosonic Incorporated
P.O. Box 618 Christiansburg, VA 24068

EIN/Tax ID:
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No